CR11384A - Proteina m de estreptococo, fragmentos inmunogenicos, acidos nucleicos y metodos de uso - Google Patents

Proteina m de estreptococo, fragmentos inmunogenicos, acidos nucleicos y metodos de uso

Info

Publication number
CR11384A
CR11384A CR11384A CR11384A CR11384A CR 11384 A CR11384 A CR 11384A CR 11384 A CR11384 A CR 11384A CR 11384 A CR11384 A CR 11384A CR 11384 A CR11384 A CR 11384A
Authority
CR
Costa Rica
Prior art keywords
nucleic acids
streptococo
protein
methods
immunogenic fragments
Prior art date
Application number
CR11384A
Other languages
English (en)
Inventor
Cartner Barnes Andrew
Craig Forrester Baiano Justice
Original Assignee
Univ Queensland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Queensland filed Critical Univ Queensland
Publication of CR11384A publication Critical patent/CR11384A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invencion se refiere a proteinas y acidos nucleicos particulares. Mas particularmente, la presente invencion se refiere a proteinas aisladas y acidos nucleicos de Streptococcus. iniae y su uso en el diagnostico y/o terapia de infecciones por Streptococcus. iniae en animales, particularmente en peces.
CR11384A 2007-10-25 2010-04-23 Proteina m de estreptococo, fragmentos inmunogenicos, acidos nucleicos y metodos de uso CR11384A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US98254007P 2007-10-25 2007-10-25

Publications (1)

Publication Number Publication Date
CR11384A true CR11384A (es) 2010-07-16

Family

ID=40578972

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11384A CR11384A (es) 2007-10-25 2010-04-23 Proteina m de estreptococo, fragmentos inmunogenicos, acidos nucleicos y metodos de uso

Country Status (7)

Country Link
US (1) US20100215684A1 (es)
CN (1) CN101918435A (es)
BR (1) BRPI0818715A2 (es)
CR (1) CR11384A (es)
HN (1) HN2010000718A (es)
TW (1) TW200930401A (es)
WO (1) WO2009052572A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8406089B2 (en) * 2009-09-04 2013-03-26 Headway Technologies, Inc. Heat-assisted magnetic recording head with laser diode fixed to slider
CN103642802A (zh) * 2013-12-03 2014-03-19 中国水产科学研究院淡水渔业研究中心 吉富罗非鱼抗海豚链球菌感染家系的分子标记及筛选方法
US9894070B2 (en) * 2014-08-27 2018-02-13 Aruba Networks, Inc. Method and system for controlling access to shared devices
CN116983397B (zh) * 2023-09-28 2024-01-26 中国海洋大学 海豚链球菌dna疫苗、制备方法及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9713355A (pt) * 1996-11-14 2000-01-25 Univ Saskatchewan Proteìna de ligação à lactoferrina d streptococcus uberis
US20090162401A1 (en) * 2005-02-18 2009-06-25 Buchanan John T Streptococcus Iniae Phosphoglucomutase is a Virulence Factor and Target for Vaccine Development

Also Published As

Publication number Publication date
US20100215684A1 (en) 2010-08-26
CN101918435A (zh) 2010-12-15
WO2009052572A1 (en) 2009-04-30
HN2010000718A (es) 2011-08-26
TW200930401A (en) 2009-07-16
BRPI0818715A2 (pt) 2017-05-02

Similar Documents

Publication Publication Date Title
BRPI0819714A2 (pt) Formulações de proteína e métodos de produção das mesmas.
CY1123052T1 (el) Συνθεσεις και μεθοδοι σχετικες με παραλλαγες της πρωτεϊνες α (spa)
CY1118576T1 (el) Πρωτεϊνες δεσμευομενες με αντιγονο ανθρωπινης il-23
CY1118880T1 (el) Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
CO6680687A2 (es) Inmunoglobinas con dominio variable dual capaces de unirse a il 1 beta e il-17, composiciones farmaceúticas y conjugados de proteína de unión de las mismas
CY1118760T1 (el) Τροποποιημενα αντισωματα εναντι il-23
PA8772101A1 (es) Imidazol-triazolopirimidinas sustituidas
CY1116842T1 (el) Ειδικα εξανθρωπισμενα αντισωματα στην πρωτοϊνιδιακη μορφη του βητα-αμυλοειδους πεπτιδιου
HN2006016512A (es) Anticuerpos anti-il-6, composiciones, metodos y usos
CR11282A (es) Proteinas enlazadas al antigeno de celula de cepa mcdonough de felino humanas
CY1118153T1 (el) Αγωγη μικροβιακων μολυνσεων
ECSP13012436A (es) ANTICUERPOS PEPTÍDICOS BETA AMILOIDE ANTI-N3pGlu Y USOS DE LOS MISMOS
ECSP13012609A (es) Composición farmacéutica
ES2330291B1 (es) Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
AR080891A1 (es) Proteina de fusion robo 1-fc y su utilizacion en el tratamiento de tumores
PL2433954T3 (pl) Identyfikacja związanych z nowotworem antygenów w celu diagnozowania i leczenia
MX2010004179A (es) Anticuerpos anti-amiloide, composiciones, metodos y usos.
WO2014160490A8 (en) Antibody formulations
BRPI0921947A2 (pt) formulações de proteína terapêutica
BRPI0815604A2 (pt) Proteínas de streptococcus imunogênicas
UA107836C2 (uk) Метод лікування хвороби альцгеймера
EP2154148A4 (en) SHORTENED L1 PROTEIN OF THE HUMAN PAPILLOMA VIRUS 11
CL2011002994A1 (es) Construccion de proteina que comprende polipeptido casb7439; composicion inmunogenica que comprende dicha construccion; uso de la composicion porque sirve para inducir respuesta inmunitaria al casb7439 en un animal.
Douglas et al. Physiological adaptations of key oral bacteria
CR11384A (es) Proteina m de estreptococo, fragmentos inmunogenicos, acidos nucleicos y metodos de uso

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)